Hypoxia-induced CTCF promotes EMT in breast cancer
Cell Reports · 2024-07 · 43 (7) · 114367
DOI: 10.1016/j.celrep.2024.114367 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2024-07. Verfasst von Parik Kakani und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, Madhya Pradesh 462066, India. Hauptthemen laut MEDLINE: CCCTC-Binding Factor, Epithelial-Mesenchymal Transition, Breast Neoplasms, Hypoxia-Inducible Factor 1, alpha Subunit. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Wellcome Trust DBT India Alliance, Science and Engineering Research Board, University Grants Commission.
Abstract (Originalsprache)
Cancer cells experiencing hypoxic stress employ epithelial-mesenchymal transition (EMT) to undergo metastasis through rewiring of the chromatin landscape, epigenetics, and importantly, gene expression. Here, we showed that hypoxia modulates the epigenetic landscape on CTCF promoter and upregulates its expression. Hypoxia-driven epigenetic regulation, specifically DNA demethylation mediated by TET2, is a prerequisite for CTCF induction. Mechanistically, in hypoxic conditions, Hypoxia-inducible factor 1-alpha (HIF1α) binds to the unmethylated CTCF promoter, causing transcriptional upregulation. Further, we uncover the pivotal role of CTCF in promoting EMT as loss of CTCF abrogated invasiveness of hypoxic breast cancer cells. These findings highlight the functional contribution of HIF1α-CTCF axis in promoting EMT in hypoxic breast cancer cells. Lastly, CTCF expression is alleviated and the potential for EMT is diminished when the HIF1α binding is particularly disrupted through the dCas9-DNMT3A system-mediated maintenance of DNA methylation on the CTCF promoter. This axis may offer a unique therapeutic target in breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, Madhya Pradesh 462066, India.
- Department of Pathology, Bansal Hospital, Bhopal, Madhya Pradesh 462016, India.
- Department of Surgical Oncology, Bansal Hospital, Bhopal, Madhya Pradesh 462016, India.
- Department of Biological Sciences, Indian Institute of Science Education and Research Bhopal, Bhopal, Madhya Pradesh 462066, India. Electronic address: sanjeevs@iiserb.ac.in.
Förderung
- Wellcome Trust DBT India Alliance
- Science and Engineering Research Board
- University Grants Commission
- Indian Institute of Science Education and Research Bhopal
- Department of Biotechnology
Zitieren
APA
Kakani, P., Dhamdhere, S. G., Pant, D., Joshi, R., Mishra, J., Samaiya, A., & Shukla, S. (2024). Hypoxia-induced CTCF promotes EMT in breast cancer. Cell Reports, 43(7), 114367. https://doi.org/10.1016/j.celrep.2024.114367
Vancouver
Kakani P, Dhamdhere SG, Pant D, Joshi R, Mishra J, Samaiya A, et al. Hypoxia-induced CTCF promotes EMT in breast cancer. Cell Reports. 2024;43(7):114367. doi:10.1016/j.celrep.2024.114367
BibTeX
@article{Kakani2024,
author = {Kakani, Parik and Dhamdhere, Shruti Ganesh and Pant, Deepak and Joshi, Rushikesh and Mishra, Jharna and Samaiya, Atul and Shukla, Sanjeev},
title = {Hypoxia-induced CTCF promotes EMT in breast cancer},
journal = {Cell Reports},
year = {2024},
volume = {43},
number = {7},
pages = {114367},
doi = {10.1016/j.celrep.2024.114367}
}
EUVIMED